Health Library Logo

Health Library

He aha ʻo Aflibercept-ayyh: Nā hoʻohana, ka nui, nā hopena ʻaoʻao a me nā mea hou aku
He aha ʻo Aflibercept-ayyh: Nā hoʻohana, ka nui, nā hopena ʻaoʻao a me nā mea hou aku

Health Library

He aha ʻo Aflibercept-ayyh: Nā hoʻohana, ka nui, nā hopena ʻaoʻao a me nā mea hou aku

October 10, 2025


Question on this topic? Get an instant answer from August.

ʻO Aflibercept-ayyh he lāʻau lapaʻau i hoʻokomo ʻia i ka maka i hoʻohana ʻia e mālama i nā maʻi retinal koʻikoʻi e hiki ke hoʻoweliweli i kou ʻike. Hana kēia mana biosimilar o ka aflibercept kumu ma ka pale ʻana i nā protein kikoʻī e hoʻoulu ai i ka ulu ʻana o nā kīʻaha koko a me ka leaka wai i loko o kou maka. E noʻonoʻo iā ia he lāʻau lapaʻau i manaʻo ʻia e kōkua i ka hoʻihoʻi ʻana i ke kaulike palupalu e pono ai kou retina e hana pono.

He aha ʻo Aflibercept-ayyh?

ʻO Aflibercept-ayyh he lāʻau lapaʻau biosimilar e pili ana i kahi papa o nā lāʻau i kapa ʻia ʻo VEGF inhibitors. Ua hoʻolālā ʻia e hana like me ka aflibercept kumu (Eylea) akā ua hana ʻia e kahi mea hana ʻē aʻe. Kōkua ka suffix "-ayyh" e hoʻokaʻawale iā ia mai nā huahana aflibercept ʻē aʻe.

ʻO kēia lāʻau lapaʻau he protein i hana ʻia i loko o ka hale hana e hoʻohālike i ka hiki maoli o kou kino e kāohi i ka ulu ʻana o nā kīʻaha koko. Ke hoʻokomo pololei ʻia i loko o kou maka, kōkua ia e hoʻōki i nā loli maʻamau e hiki ke hōʻino i kou retina a hiki ke alakaʻi i ka nalowale o ka ʻike.

E hāʻawi kāu kauka maka i kēia lāʻau lapaʻau i kā lākou keʻena me ka hoʻohana ʻana i kahi nila lahilahi loa. E komo ka injection i loko o ka vitreous, ʻo ia ka mea e like me ka gel e hoʻopiha ana i loko o kou maka.

No ke aha i hoʻohana ʻia ai ʻo Aflibercept-ayyh?

Hoʻomaʻamaʻa ʻo Aflibercept-ayyh i kekahi mau maʻi maka koʻikoʻi e pili ana i ka ulu ʻana o nā kīʻaha koko a i ʻole ka hōʻiliʻili wai i loko o kou retina. Hiki i kāu kauka ke ʻōlelo i kēia lāʻau lapaʻau inā loaʻa iā ʻoe ka degeneration macular e pili ana i ka makahiki, diabetic macular edema, a i ʻole kekahi mau ʻano o ka retinal vein occlusion.

No ka degeneration macular e pili ana i ka makahiki, kōkua ka lāʻau lapaʻau i ka hoʻōki ʻana i nā kīʻaha koko e kahe ana mai ka ulu ʻana ma lalo o kou macula. Hoʻopilikia nui kēia maʻi i ka poʻe ma luna o 50 a hiki ke hoʻoulu i ka nalowale o ka ʻike waena inā ʻaʻole mālama ʻia.

Inā he edema macular diabetic kāu, hiki i ka aflibercept-ayyh ke hōʻemi i ka pehu ʻana i loko o kāu macula i hana ʻia e ka maʻi diabetes. Hiki mai kēia pehu ʻana ke hōʻino ke kō kiʻekiʻe i nā kīʻaha koko liʻiliʻi i loko o kou retina, e hoʻoheheʻe ai lākou i ka wai.

Hoʻomaʻamaʻa pū ka lāʻau i ka edema macular ma hope o ka occlusion vein retinal. Hiki mai kēia ke ālai ka ʻōpala koko i ke kahe ʻana i loko o kou retina, e alakaʻi ana i ka hōʻiliʻili wai a me nā pilikia ʻike.

Pehea e Hana ai ʻo Aflibercept-ayyh?

Hana ʻo Aflibercept-ayyh ma ka ālai ʻana i kahi protein i kapa ʻia ʻo VEGF e paipai ana i ka ulu ʻana o nā kīʻaha koko maʻamau ʻole i loko o kou maka. Ke kiʻekiʻe loa nā pae VEGF, hiki iā ia ke hana i nā kīʻaha koko e ulu i kahi e pono ʻole ai lākou a hoʻoheheʻe i ka wai i loko o kou retina.

E noʻonoʻo iā VEGF ma ke ʻano he hōʻailona e haʻi ana i kou kino e hana i nā kīʻaha koko hou. ʻOiai he mea kōkua kēia hana no ka hoʻōla ʻana i nā ʻeha, lilo ia i mea pilikia ke hana ia i loko o kou retina. Hana ka lāʻau e like me ka sponge, e omo ana i ka VEGF nui a pale iā ia mai ka hana ʻana i ka pōʻino.

Manaʻo ʻia kēia he lāʻau ikaika waena e kuhikuhi ana i ke kumu kumu o kekahi mau maʻi retinal. Ma ka mālama ʻana i nā pae VEGF, hiki iā ia ke kōkua i ka mālama ʻana i kāu ʻike i kēia manawa a i kekahi manawa e hoʻomaikaʻi ai.

Hoʻomaka maʻamau nā hopena i loko o nā lā a i ʻole nā pule o kāu injection mua. Eia naʻe, pono paha ʻoe i nā lāʻau lapaʻau he nui i ka manawa e mālama ai i nā pōmaikaʻi.

Pehea e Lawe ai au i ka Aflibercept-ayyh?

E hoʻokomo pololei kāu kauka maka i ka aflibercept-ayyh i loko o kou maka i ka wā o kahi kipa keʻena. ʻAʻole ʻoe e lawe i kēia lāʻau ma ka home, a ʻaʻohe hoʻomākaukau kūikawā me ka meaʻai a i ʻole ka inu e pono ai ma mua.

Ma mua o kāu injection, e hoʻomaʻemaʻe kāu kauka i kou maka a me ka wahi a puni. E hoʻohana lākou i nā kulu numbing e hōʻemi i ka hōʻoluʻolu i ka wā o ke kaʻina hana. He mau kekona wale nō ka injection maoli.

Pono ʻoe e hoʻolālā e loaʻa i kekahi e kalaiwa iā ʻoe i ka home ma hope o kāu manawa. Hiki ke pōpō iki kou ʻike, a e ʻoluʻolu iki paha kou maka no kekahi mau hola.

Ma hope o ka hoʻokomo ʻana, hiki iā ʻoe ke ʻai a inu maʻamau. Eia naʻe, e pale i ka hamo ʻana i kou maka i mālama ʻia a mālama maʻemaʻe e like me nā ʻōlelo a kāu kauka. Hiki i ka hapa nui o nā kānaka ke hoʻi i kā lākou hana maʻamau i ka lā aʻe.

Pehea ka lōʻihi e lawe ai au i ka Aflibercept-ayyh?

ʻO ka lōʻihi o ka mālama ʻana i ka aflibercept-ayyh e loli ana ma muli o kou kūlana kikoʻī a me ka maikaʻi o kou pane ʻana i ka lāʻau. Nui ka poʻe e pono i ka mālama ʻana no nā mahina a i ʻole nā makahiki e mālama i ko lākou hoʻomaikaʻi ʻana i ka ʻike.

I ka wā mua, e loaʻa paha iā ʻoe nā injections i kēlā me kēia 4 a 8 pule. E nānā pono kāu kauka i kāu holomua a hiki ke hoʻololi i kēia papa manawa ma muli o ke ʻano o ka pane ʻana o kou maka. Pono kekahi poʻe i nā injections i ka liʻiliʻi pinepine.

ʻO ka maʻamau, he maʻi maʻi kou maka, ʻo ia hoʻi, pono ia i ka mālama lōʻihi ma mua o ka lāʻau. E noʻonoʻo i kēia mau injections e like me ka lawe ʻana i ka lāʻau koko - kōkua lākou i ka mālama ʻana i kou kūlana akā pono e hoʻomau ʻia e mālama i nā pōmaikaʻi.

He mea nui nā manawa ukali maʻamau inā paʻa kou ʻike. E hoʻohana kāu kauka i nā hoʻokolohua kiʻi kūikawā e nānā i nā loli i kou retina i ʻike ʻole ʻia e ʻoe.

He aha nā hopena ʻaoʻao o Aflibercept-ayyh?

ʻO ka hapa nui o nā kānaka e ʻae maikaʻi i ka aflibercept-ayyh, akā e like me nā lāʻau lapaʻau, hiki iā ia ke hana i nā hopena ʻaoʻao. ʻO nā mea maʻamau ka maʻamau a me ka manawa, ʻoiai he kakaikahi nā pilikia koʻikoʻi akā he mea nui e ʻike.

Eia nā hopena ʻaoʻao āu e ʻike ai, e hoʻomaka ana me nā mea maʻamau:

  • Ka huhū o ka maka, ka ʻulaʻula, a i ʻole ka ʻoluʻolu e mau ana no kekahi mau hola ma hope o ka hoʻokomo ʻana
  • Ka ʻike pōpō no ka manawa pōkole a i ʻole ka ʻike ʻana i nā kiko lana
  • Ka ʻeha o ka maka māmā a i ʻole ka manaʻo e like me ka mea i loko o kou maka
  • Hoʻonui ʻia ka hana waimaka a i ʻole nā maka wai
  • Hoʻonui iki i ke kaomi o ka maka

Hoʻoponopono maʻamau kēia mau hopena ʻaoʻao i loko o hoʻokahi a ʻelua paha lā a ʻaʻole pono i ka mālama kūikawā ma mua o ka hahai ʻana i nā ʻōlelo aʻo ma hope o ka mālama ʻana a kāu kauka.

ʻO nā hopena ʻaoʻao maʻamau ʻole akā ʻoi aku ka hopohopo e pili ana i ka ʻeha nui o ka maka, nā loli ʻike koke, a i ʻole nā hōʻailona o ka maʻi e like me ka hoʻonui ʻana i ka ʻulaʻula, ka hoʻokuʻu ʻana, a i ʻole ka pehu. Pono kēia mau mea i ka lāʻau lapaʻau koke.

ʻO nā pilikia maʻamau loa akā koʻikoʻi e pili ana i ka wehe ʻana o ka retina, ka mumū nui i loko o ka maka, a i ʻole nā koko koko. ʻOiai e hana ʻia kēia mau mea ma lalo o 1% o nā maʻi, pono lākou i ka lāʻau lapaʻau pilikia e pale ai i ka nalowale ʻana o ka ʻike mau.

Hiki i kekahi poʻe ke ʻike i nā hopena ʻōnaehana e like me ke poʻo, ke koko kiʻekiʻe, a i ʻole nā koko koko ma nā wahi ʻē aʻe o ke kino. He mea maʻamau loa kēia mau mea akā ʻoi aku ka nui o ka poʻe me nā maʻi cardiovascular.

ʻO wai ka mea pono ʻole e lawe iā Aflibercept-ayyh?

ʻAʻole kūpono ʻo Aflibercept-ayyh no nā mea a pau, a e loiloi pono kāu kauka inā palekana ia iā ʻoe. ʻAʻole pono ka poʻe me nā maʻi maka ikaika a i ʻole ka mumū nui i loko a i ʻole a puni ka maka e loaʻa i kēia lāʻau.

Inā he maʻi ʻoe iā aflibercept a i ʻole kekahi o kāna mau mea, ʻaʻole pono ʻoe e hoʻohana i kēia lāʻau. E nānā kāu kauka i kāu mōʻaukala maʻi ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau.

Pono ka poʻe me kekahi mau maʻi cardiovascular i ka noʻonoʻo kūikawā. Inā ua loaʻa iā ʻoe kahi hahau, puʻuwai puʻuwai, a i ʻole ke koko koko, e kaupaona kāu kauka i nā pōmaikaʻi e kūʻē i nā pilikia hiki ke loaʻa ma mua o ka ʻōlelo ʻana i ka lāʻau lapaʻau.

Pono nā wāhine hāpai e pale i ka aflibercept-ayyh ke ʻole ka maikaʻi e ʻoi aku ma mua o nā pilikia. Hiki i ka lāʻau lapaʻau ke hōʻeha i kahi pēpē e ulu ana, no laila he mea nui ka pale ʻana i ka hāpai ʻana i ka wā e mālama ʻia ai.

Inā ʻoe e hānai ana i ka waiū, e kūkākūkā me kāu kauka. ʻOiai ʻaʻole maopopo ka nui o ka lāʻau lapaʻau e hele i loko o ka waiū umauma, hiki i kāu kauka ke kōkua iā ʻoe e hana i kahi hoʻoholo i ʻike ʻia e pili ana i ka manawa o ka mālama ʻana.

Nā inoa inoa o Aflibercept-ayyh

Loaʻa ka Aflibercept-ayyh ma lalo o ka inoa inoa Opuviz. Hāʻawi kēia mana biosimilar i nā pōmaikaʻi therapeutic like me ka aflibercept mua (Eylea) akā hiki ke loaʻa ma ke kumu kūʻai haʻahaʻa.

Hiki ke ʻokoʻa kāu ʻinikua ma waena o nā mana mua a me nā mana biosimilar. Hiki i ke keʻena o kāu kauka ke kōkua iā ʻoe e hoʻomaopopo i ka koho e hana maikaʻi loa me kāu hoʻolālā ʻinikua.

Loaʻa i nā mana ʻelua ka mea hana like a hana like i kou maka. ʻO ke koho ma waena o lākou e pili pinepine ana i ka ʻinikua, ka loaʻa, a me nā manaʻo kumukūʻai.

Nā koho ʻē aʻe o Aflibercept-ayyh

Nui nā lāʻau lapaʻau ʻē aʻe e hiki ke mālama i nā maʻi maka like inā ʻaʻole kūpono ka aflibercept-ayyh iā ʻoe. ʻO Bevacizumab (Avastin) a me ranibizumab (Lucentis) nā mea pale VEGF ʻē aʻe e hana ana ma nā ʻano like.

ʻO Brolucizumab (Beovu) kahi koho hou e hiki ai i nā manawa lōʻihi ma waena o nā injections. Eia naʻe, lawe ia i kahi pilikia liʻiliʻi o ka mumū nui i kekahi mau maʻi.

No kekahi mau maʻi, hiki i kāu kauka ke ʻōlelo aku i nā lāʻau lapaʻau laser a i ʻole photodynamic therapy ma kahi o a i ʻole i hui pū ʻia me nā injections maka. Hana ʻokoʻa kēia mau koho ʻē aʻe akā hiki ke maikaʻi no nā kūlana kikoʻī.

Aia ka mālama maikaʻi loa i kāu maʻi kikoʻī, ka mōʻaukala olakino, a me nā makemake pilikino. E kōkua kāu kauka maka iā ʻoe e hoʻomaopopo i nā koho a pau i loaʻa a me kā lākou mau mea maikaʻi a me nā mea maikaʻi ʻole.

Ua ʻoi aku ka maikaʻi o Aflibercept-ayyh ma mua o Ranibizumab?

He mea pono ʻo Aflibercept-ayyh a me ranibizumab no ka mālama ʻana i nā maʻi retina, akā he mau ʻokoʻa ko lākou e hiki ai ke kūpono kekahi no ʻoe. Hōʻike nā haʻawina lapaʻau e ʻae pinepine ʻo aflibercept i nā manawa lōʻihi ma waena o nā injections i hoʻohālikelike ʻia me ranibizumab.

He nui nā mea maʻi e loaʻa ana i nā injections aflibercept i kēlā me kēia 6 a 8 pule ma hope o ka mālama mua ʻana, ʻoiai ʻo ranibizumab e koi pinepine i nā injections i kēlā me kēia mahina. ʻO ia hoʻi, ʻoi aku ka liʻiliʻi o nā kipa kauka a me nā kaʻina hana me aflibercept.

He like ka pono o nā lāʻau lapaʻau ʻelua i ka mālama ʻana a me ka hoʻomaikaʻi ʻana i ka ʻike. Hele pinepine ka koho i kāu maʻi kikoʻī, pehea ʻoe e pane ai i ka mālama ʻana, a me nā mea e pono ai e like me ke alapine o ka injection.

E noʻonoʻo kāu kauka i nā mea e like me kou ola, ka papa huakaʻi, a me ka hiki ke hele i nā manawa pinepine i ka wā e ʻōlelo ai ma waena o kēia mau koho. He mau koho maikaʻi ʻelua me nā moʻolelo i hōʻoia ʻia.

Nā Nīnau i Nīnau Pinepine ʻia e pili ana iā Aflibercept-ayyh

He palekana anei ʻo Aflibercept-ayyh no ka poʻe me ka maʻi diabetes?

ʻAe, palekana ʻo aflibercept-ayyh no ka poʻe me ka maʻi diabetes a hoʻohana pinepine ʻia e mālama i ka edema macular diabetic. Eia naʻe, e nānā pono kāu kauka iā ʻoe no ka mea hiki i ka maʻi diabetes ke hoʻopilikia i ka hoʻōla a hoʻonui i ka pilikia o ka maʻi.

Pono ka poʻe me ka maʻi diabetes e mālama i ka mana maikaʻi o ke kō koko i ka wā o ka mālama ʻana. Hiki i ka hoʻokele maikaʻi ʻana i ka maʻi diabetes ke hoʻomaikaʻi i kāu pane ʻana i nā injections maka a hoʻemi i ka pilikia o nā pilikia.

He aha kaʻu e hana ai inā hoʻohana hewa au i ka nui o Aflibercept-ayyh?

No ka mea, ua lawelawe ʻia ʻo aflibercept-ayyh e kāu kauka i kahi hoʻonohonoho lapaʻau, ʻaʻole hiki ke loaʻa ka overdose. Ua ana mua ʻia ka lāʻau lapaʻau i loko o nā vials hoʻohana hoʻokahi e pale ai i nā hewa dosing.

Inā hopohopo ʻoe e pili ana i kāu injection a i ʻole e ʻike i nā hōʻailona maʻamau ma hope o ka mālama ʻana, e hoʻokaʻaʻike koke i kāu kauka maka. Hiki iā lākou ke loiloi inā pono ʻoe i ka nānā ʻana a i ʻole ka mālama ʻana.

He aha kaʻu e hana ai inā ua hala wau i kahi mahele o Aflibercept-ayyh?

Inā ua hala ʻoe i kahi manawa hoʻopaʻa ʻia no ka hoʻokomo ʻana, e hoʻonohonoho hou iā ia i ka wā hiki wawe. Mai kali a hiki i kāu manawa i hoʻonohonoho mau ʻia, no ka mea, hiki i kēia ke ʻae i kou maʻi e ʻino.

E kelepona i ke keʻena o kāu kauka e hoʻonohonoho i kahi manawa hou. Hiki iā lākou ke makemake e nānā i kou maka ma mua o ka hoʻomau ʻana me ka hoʻokomo ʻana i hoʻopanee ʻia e loiloi i nā loli i kou maʻi.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Aflibercept-ayyh?

Mai hooki i nā lāʻau lapaʻau aflibercept-ayyh me ka ʻole e kūkākūkā mua me kāu kauka maka. Pono ka hapa nui o nā maʻi retinal i ka lāʻau lapaʻau e mālama i ka hoʻomaikaʻi ʻana i ka ʻike a pale i ka holomua.

E loiloi mau kāu kauka inā pono ʻoe i nā injections e pili ana i kāu mau hoʻokolohua maka a me nā hoʻokolohua kiʻi. Hiki i kekahi poʻe ke pono i nā lāʻau lapaʻau liʻiliʻi, akā ʻaʻole ʻōlelo ʻia ka hoʻopau ʻana.

Hiki iaʻu ke kalaiwa ma hope o ka loaʻa ʻana o Aflibercept-ayyh?

ʻAʻole pono ʻoe e kalaiwa koke ma hope o kāu manawa hoʻokomo. Hiki i nā kulu numbing a me nā loli ʻike manawa ke hoʻopilikia i kou hiki ke kalaiwa palekana.

E hoʻolālā e loaʻa i kekahi e kalaiwa iā ʻoe i ka home ma hope o kāu manawa. Hiki i ka hapa nui o nā kānaka ke hoʻomau i ke kalaiwa i ka lā aʻe ke pau nā hopena ʻike manawa.

Health Companion

trusted by

6Mpeople

Get clear medical guidance
on symptoms, medications, and lab reports.

QR code to download August

download august